China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research report sent to investors on Saturday. The firm issued a hold rating on the stock.

China Pharma Stock Performance

NYSE CPHI opened at $0.31 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.33 and a debt-to-equity ratio of 0.19. The business’s 50 day moving average is $0.38 and its two-hundred day moving average is $0.47. China Pharma has a 12-month low of $0.30 and a 12-month high of $2.70.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.